Compare CMPS & EHAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CMPS | EHAB |
|---|---|---|
| Founded | 2020 | 2014 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hospital/Nursing Management |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 778.7M | 690.9M |
| IPO Year | 2020 | 2020 |
| Metric | CMPS | EHAB |
|---|---|---|
| Price | $5.49 | $13.66 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 5 |
| Target Price | ★ $27.14 | $13.84 |
| AVG Volume (30 Days) | ★ 2.4M | 1.7M |
| Earning Date | 03-24-2026 | 03-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 97.11 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,060,000,000.00 |
| Revenue This Year | N/A | $6.42 |
| Revenue Next Year | N/A | $4.88 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 2.44 |
| 52 Week Low | $2.25 | $6.47 |
| 52 Week High | $8.90 | $13.66 |
| Indicator | CMPS | EHAB |
|---|---|---|
| Relative Strength Index (RSI) | 36.12 | 79.43 |
| Support Level | $4.78 | $10.79 |
| Resistance Level | $7.02 | N/A |
| Average True Range (ATR) | 0.40 | 0.03 |
| MACD | -0.16 | -0.11 |
| Stochastic Oscillator | 21.37 | 87.50 |
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.
Enhabit Inc provides home health and hospice services in the United States. Its reportable segments are Home Health and Hospice. The Home Health segment includes a comprehensive range of Medicare-certified home nursing services for adult patients in need of care. These services include, among others, skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. The Hospice segment focuses on the quality of life for patients who are experiencing a life-limiting illness while treating the person and symptoms of the disease, rather than the disease itself. The company generates a majority of its revenue from the Home Health segment.